Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countries
Jan 1, 2024·,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,·
0 min read
Gonzalo R. Quintana
Fernando P. Ponce
Javier I. Escudero-Pastén
Juan F. Santibáñez-Palma
Léna Nagy
Mónika Koós
Shane W. Kraus
Zsolt Demetrovics
Marc N. Potenza
Rafael Ballester-Arnal
Dominik Batthyány
Sophie Bergeron
Joël Billieux
Peer Briken
Julius Burkauskas
Georgina Cárdenas-López
Joana Carvalho
Jesús Castro-Calvo
Lijun Chen
Giacomo Ciocca
Ornella Corazza
Rita I. Csako
David P. Fernandez
Elaine F. Fernandez
Hironobu Fujiwara
Johannes Fuss
Roman Gabrhelík
Ateret Gewirtz-Meydan
Biljana Gjoneska
Mateusz Gola
Joshua B. Grubbs
Hashim T. Hashim
Md. Saiful Islam
Mustafa Ismail
Martha C. Jiménez-Martínez
Tanja Jurin
Ondrej Kalina
Verena Klein
András Költő
Chih-Ting Lee
Sang-Kyu Lee
Karol Lewczuk
Chung-Ying Lin
Christine Lochner
Silvia López-Alvarado
Kateřina Lukavská
Percy Mayta-Tristán
Dan J. Miller
Oľga Orosová
Gábor Orosz
Gabriel C. Quintero Garzola
Jano Ramos-Diaz
Kévin Rigaud
Ann Rousseau
Marco De Tubino Scanavino
Marion K. Schulmeyer
Pratap Sharan
Mami Shibata
Sheikh Shoib
Vera Sigre-Leirós
Luke Sniewski
Ognen Spasovski
Vesta Steibliene
Dan J. Stein
Berk C. Ünsal
Marie-Pier Vaillancourt-Morel
Marie Claire Van Hout
Beáta Bőthe
Abstract
Background Depression and anxiety are among the most prevalent mental health issues experienced worldwide. However, whereas cross-cultural studies utilize psychometrically valid and reliable scales, fewer can meaningfully compare these conditions across different groups. To address this gap, the current study aimed to psychometrically assess the Brief Symptomatology Index (BSI) in 42 countries. Methods Using data from the International Sex Survey (N = 82,243; Mage = 32.39; SDage = 12.52; women: n = 46,874; 57 %), we examined the reliability of depression and anxiety symptom scores of the BSI-18, as well as evaluated evidence of construct, invariance, and criterion-related validity in predicting clinically relevant variables across countries, languages, genders, and sexual orientations. Results Results corroborated an invariant, two-factor structure across all groups tested, exhibiting excellent reliability estimates for both subscales. The ‘caseness’ criterion effectively discriminated among those at low and high risk of depression and anxiety, yielding differential effects on the clinical criteria examined. Limitations The predictive validation was not made against a clinical diagnosis, and the full BSI-18 scale was not examined (excluding the somatization sub-dimension), limiting the validation scope of the BSI-18. Finally, the study was conducted online, mainly by advertisements through social media, ultimately skewing our sample towards women, younger, and highly educated populations. Conclusions The results support that the BSI-12 is a valid and reliable assessment tool for assessing depression and anxiety symptoms across countries, languages, genders, and sexual orientations. Further, its caseness criterion can discriminate well between participants at high and low risk of depression and anxiety.
Type
Publication
Journal of Affective Disorders

Authors
Associate Professor of Psychology · Licensed Clinical Psychologist
Joshua Grubbs is an Associate Professor of Psychology at the University of New Mexico and an
Investigator at the Center on Alcohol, Substance use, And Addictions (CASAA), where he directs
the Behavioral Addictions And Associated Disorders (BAAAD) Lab. His research examines gambling
and sports betting, compulsive sexual behavior, and alcohol use, with a focus on how social,
moral, and policy contexts shape addictive behavior.